Delivery Order SPE2DB22D2007-SPE2DB24FH9DQ
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract worth $48,621.84 to provide VYVGART 400 MG/20 ML VIAL 20ML pharmaceutical products. This contract has a completion date of March 12, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor for this award. This delivery order contract is issued under a larger indefinite delivery contract (IDC)...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp., a major pharmaceutical distribution company, a delivery order contract worth $35,965.17 for the supply of 400 mg/20 ml vials of the medication VYVGART. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical division, which serves as the primary vehicle for the company to provide a comprehensive range of...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the for-profit global pharmaceutical company AmerisourceBergen Corporation. The contract, valued at $16,207.28, is for the delivery of the pharmaceutical product VYVGART 400 MG/20 ML VIAL 20ML. The order has an ultimate completion date of April 1, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $23,976.78 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) for 400 mg/20 ml vials of the pharmaceutical product VYVGART. This delivery order has a completion date of November 17, 2023. Amerisourcebergen Drug Corp serves as a prime contractor providing pharmaceutical products and medical supplies to U.S. government agencies, including the Department of Defense. The company...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of VYVGART 400 mg/20 ml vials totaling $12,792.51 with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's substantial...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract has a potential value of $8,103.66 and a completion date of March 25, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, with a potential value of up to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $34,113.36, is for the provision of VYVGART 400 MG/20 ML VIAL 20ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of February 12, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a $12,792.51 firm fixed-price delivery order contract awarded by the Defense Logistics Agency to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the pharmaceutical product VYVGART 400 MG/20 ML VIAL 20ML, with an ultimate completion date of July 1, 2025. The contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This is a firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of VYVGART 400 MG/20 ML VIAL 20ML, a pharmaceutical product. The contract has a ceiling value of $8,103.66 and an ultimate completion date of October 4, 2024. AmerisourceBergen is a major supplier of pharmaceutical and medical products to the U.S. federal government, including military treatment facilities and veterans' hospitals. This award is part of a larger...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company, to provide 4564949277 VYVGART 400 MG/20 ML VIAL 20ML. The contract, valued at $24,310.92, has a completion date of July 10, 2024. Amerisourcebergen also holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, the primary vehicle for delivering a range of pharmaceutical...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB24FH9DQDelivery Order
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a division of Amerisourcebergen Corporation, for the supply of VYVGART 400 MG/20 ML VIAL 20ML pharmaceutical products. The contract has a potential value of $16,207.28 and a completion date of February 23, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this award and serves as a supplier of pharmaceuticals and medical supplies to various U.S. government agencies, including the Department of Defense. This delivery order is not associated with any set-aside designation. Additionally, Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00, which serves as the primary contract vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.2k | 2/1/24 |